Centene price to free cash flow CNC
Market value divided by free cash flow over the last twelve months, since 2011.
- Today, Oct 23, 2026
- 3.9×
- 10-year median
- 11.9×
- Against its 10-year history
- 3rd
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 3.4× to 336×
- Peer median
- 12.7×
Centene's price to free cash flow is 3.9× as of Oct 23, 2026.
That is below its ten-year median of 11.9×, lower than on 97% of days in the last ten years.
Over that time it ranged from 3.4× in Sep 2026 to 336× in May 2019.
The median for 5 health insurers of a similar size is 12.7×.
Price to free cash flow over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 3.9× | 3.4× | 6.8× |
| 2025 | 5.9× | 5.2× | 133× |
| 2024 | 125× | 5.2× | 132× |
| 2023 | 7.3× | 4.1× | 7.4× |
| 2022 | 6.2× | 6.2× | 15.7× |
| 2021 | 8.5× | 7.3× | 39.2× |
| 2020 | 34.5× | 16.7× | 55.6× |
| 2019 | 33.6× | 11.9× | 336× |
| 2018 | 13.6× | 7.7× | 23.8× |
| 2017 | 7.8× | 5.0× | 60.5× |
| 2016 | 49.3× | 9.3× | 55.1× |
| 2015 | 11.4× | 6.1× | 11.4× |
| 2014 | 6.7× | 5.8× | 27.0× |
| 2013 | 25.1× | 5.5× | 26.3× |
| 2012 | 5.2× | 5.0× | 30.6× |
| 2011 | 7.7× | 4.8× | 7.9× |
Against its peers
Companies in Medical - Healthcare Plans nearest Centene's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| CNCCentene | 3.9× |
| HUMHumana | 26.0× |
| CICigna | n/m |
| ELVElevance Health | 15.2× |
| CVSCVS Health | 10.2× |
| OSCROscar Health | 2.2× |
| Peer median | 12.7× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Centene
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.